首页> 中文期刊> 《精神医学杂志》 >重复经颅磁刺激联合帕罗西汀治疗创伤后应激障碍的效果观察

重复经颅磁刺激联合帕罗西汀治疗创伤后应激障碍的效果观察

         

摘要

目的:观察重复经颅磁刺激(rTMS)联合帕罗西汀对创伤后应激障碍(PTSD)的疗效及安全性。方法将56例PTSD患者随机分为研究组(帕罗西汀联合rTMS治疗)28例和对照组(帕罗西汀治疗)28例,均治疗4周。于治疗前及治疗后第4周末采用创伤后应激障碍检查表(PCL)及汉密尔顿焦虑量表(HAMA)评定。结果两组治疗后第4周末PCL总分评分差及各因子分均较各自治疗前降低(P<0.05),研究组PCL总分评分差及各因子评分差均高于对照组(P<0.05);治疗后第4周末两组HAMA评分均较各自治疗前低(P<0.05),研究组HAMA评分低于对照组(P<0.05);两组间总不良反应发生率比较差异无统计学意义(P>0.05)。结论联用rTMS能够增加帕罗西汀对PTSD的重现、回避、高警觉核心症状以及焦虑症状的疗效。%Objective To observe the effect and safety of repetitive transcranial magnetic stimulation (rTMS)combined with paroxetine in the treatment of post-traumatic stress disorder (PTSD).Methods 56 patients with PTSD were randomized into study group(28 cases)treated with rTMS combined with paroxetine and control group (28 cases)treated with paroxetine monotherapy for 4 weeks.All patients in both groups were assessed with PTSD Checklist (PCL)and Hamilton Anxiety Rating Scale (HAMA)at baseline and at the end of the treatment.Results At the end of the 4-week treatment,total score and all factor scores of PCL in both groups decreased significantly when compared with the baseline (P<0.05 ).The decrease of total score and all factor scores of PCL in study group were significantly higher than those in control group (P<0.05).At the end of the treatment,total scores of HAMA in both groups were significantly lower than the baseline (P<0.05 ),and total score of HAMA in study group was significantly lower than that in control group (P<0.05 ).No significant difference was found in incidence rate of side effects between the two groups (P<0.05).Conclusion Combination with rTMS can enhance the effect of paroxetine on symptoms of flash-back,evasion,hyperarousal and anxiety in PTSD.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号